Evidence map›Paper›PMID 18487194›Full record

ArticleScience (New York, N.Y.)2008

Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E. coli.

Christopher J Cardinale, Robert S Washburn, Vasisht R Tadigotla, Lewis M Brown, Max E Gottesman, Evgeny Nudler

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 312 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Predicting clinical outcome ofMicrobial genomics · 2025
    Article
  7. Article
  8. KilR ofmSphere · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher J CardinaleDepartment of Biochemistry, New York University School of Medicine, New York, NY 10016, USA.
Robert S Washburn
Vasisht R Tadigotla
Lewis M Brown
Max E Gottesman
Evgeny Nudler
Rutgers, The State University of New Jersey · USColumbia University · US

Funding

CONTROL OF TRANSCRIPTION TERMINATION IN E. COLIR01GM037219 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GOTTESMAN, MAX ELLIOT · 1986 to 2017
$6.6M
Transcription Termination and its Regulation in E. coliR01GM058750 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NUDLER, EVGENY A · 1999 to 2014
$6.3M
Transcription Elongation Control in E. coliR01GM072814 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NUDLER, EVGENY A · 2005 to 2008
$1.2M
NIGMS NIH HHS GM72814NIGMS NIH HHS R01 GM037219NIGMS NIH HHS R01 GM058750NIGMS NIH HHS R01 GM072814NIGMS NIH HHS R01 GM37219NIGMS NIH HHS R01 GM58750
6 · The paper itself

Abstract

Transcription of the bacterial genome by the RNA polymerase must terminate at specific points. Transcription can be terminated by Rho factor, an essential protein in enterobacteria. We used the antibiotic bicyclomycin, which inhibits Rho, to assess its role on a genome-wide scale. Rho is revealed as a global regulator of gene expression that matches Escherichia coli transcription to translational needs. We also found that genes in E. coli that are most repressed by Rho are prophages and other horizontally acquired portions of the genome. Elimination of these foreign DNA elements increases resistance to bicyclomycin. Although rho remains essential, such reduced-genome bacteria no longer require Rho cofactors NusA and NusG. Deletion of the cryptic rac prophage in wild-type E. coli increases bicyclomycin resistance and permits deletion of nusG. Thus, Rho termination, supported by NusA and NusG, is required to suppress the toxic activity of foreign genes.

Indexed as

Gene SilencingAnti-Bacterial AgentsBacteriophage lambdaBridged Bicyclo Compounds, HeterocyclicColiphagesDNA, IntergenicEscherichia coliEscherichia coli O157Escherichia coli ProteinsGene Expression Regulation, BacterialGenome, BacterialOligonucleotide Array Sequence AnalysisPeptide Elongation FactorsProphagesProteomeRho FactorAnti-Bacterial AgentsbicozamycinBridged Bicyclo Compounds, HeterocyclicDNA, IntergenicEscherichia coli ProteinsnusA protein, E coliNusG protein, E coliPeptide Elongation FactorsProteomeRho FactorTranscriptional Elongation FactorsTranscription Factors

Identifiers

PMID18487194
PMCPMC4059013
OpenAlexW2121407329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.